Vnitr Lek 2005, 51(10):1062-1065

Vysoká prevalence a špatná kontrola hypertenze v ordinacích praktických lékařů - editorial

H. Rosolová
Centrum preventivní kardiologie II. interní kliniky LF UK a FN, Plzeň, přednosta doc. MUDr. Jan Filipovský, CSc.

Received: February 28, 2005; Published: October 1, 2005  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Rosolová H. Vysoká prevalence a špatná kontrola hypertenze v ordinacích praktických lékařů - editorial. Vnitr Lek. 2005;51(10):1062-1065.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Mancia G, Pessina AC, Trimarco B et al. On behalf of the SILVIA Study Group: Blood pressure control according to new guidelines targets in low- to high-risk hypertensives managed in specialist practice. J Hypertens 2004; 22: 2387-2396. Go to original source... Go to PubMed...
    2. Šimon J, Novák K, Dvořák J et al. Studie krevního tlaku v průmyslovém závodě. Prakt Lék 1976; 576: 664-667.
    3. Rakická E. Problematika arteriální hypertenze ve velkoměstské populaci mužů středního věku. Kandidátská disertační práce, Praha IKEM 1984.
    4. Folsom AR, Luepker RV, Gillum RF et al. Improvement in Hypertension Detection and Control from 1973-74 to 1980-81. The Minnesota Heart Experience. JAMA 1983; 250: 916-921. Go to original source...
    5. Píša Z, Škodová Z, Cícha L et al. Krevní tlak a kontrola hypertenze v populaci ČSR. Prakt Lék 1989; 69: 213-216.
    6. Rosolová H, Šimon J, Šefrna F. Zlepšení detekce a kontroly hypertenze v průmyslové populaci s.p. Škoda Plzeň od r. 1976 do r. 1986. Čas Lék Čes 1990; 129: 273-277.
    7. Rosolová H, Šimon J, Šefrna F. Improvement in arterial hypertension detection and control in industrial population of Skoda Works in Pilsen from 1976 to1986. Philippine J Cardiol 1990; 14: 328.
    8. Mayer O jr. Vývoj mortality a rizika ICHS v západočeské populaci po roce 1989. Disertační práce, Plzeň 1998.
    9. Farmer RG, Gifford RW jr, Hines HE jr et al. Effect of medical treatment of severe hypertension. Arch Intern Med 1963; 112: 118-128. Go to original source... Go to PubMed...
    10. EUROASPIRE II Study Group: Lifestyle and risk factor managements and use of drug therapies in coronary patients from 15 countries. Principal results from EUROASPIRE II, Euro Heart Survey Programme. Europ Heart J 2001; 22: 554-572. Go to original source... Go to PubMed...
    11. Šimon J. Epidemiologie a prevence ischemické choroby srdeční. Doktorská dizertační práce. Plzeň 1984.
    12. Dahlöf B, Devereux R, Kjeldsen S et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol. LANCET 2002, 359: 995-1003. Go to original source... Go to PubMed...
    13. Pepine CJ, Handberg EM, Cooper-De Hoff RM et al. A Calcium Antagonist vs a Non-Calcium Antagonist Hypertension Treatment Strategy for Patients with Coronary Artery Disease. The International Verapamil - Trandolapril Study (INVEST): A Randomized Controlled Trial. JAMA 2003; 290: 2805-2816. Go to original source... Go to PubMed...
    14. Rosolová H. Longitudinální primárně preventivní studie ICHS u mužů středního věku v průmyslové populaci. Kandidátská dizertační práce. Plzeň 1990.
    15. The Heart Outcomes Prevention Evaluation Study Investigators (HOPE): Effects of an angiotensin-converting-enzyme inhibitor, Ramipril, on cardiovascular events in high risk patients. New Engl J Med 2000; 342: 145-153. Go to original source... Go to PubMed...
    16. Bosch J, Lonn E. HOPE TOO: Heart Outcomes Prevention Evaluation - The Ongoing Outcomes. Presented at the ESC Congress 2003; Aug 30 - Sept 3, 2003, Vienna, Austria (www.medscape.com).
    17. Progress Collaborative Group: Randomised trial of perindopril - based pressure lowering regimen among 6105 patients with prior stroke or transient ischemia attack. Lancet 2001; 358: 1033-1041. Go to original source... Go to PubMed...
    18. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease; randomised double blind, placebo-controlled, mullricentre trial (the EUROPA study). Lancet 2003; 362: 782-788.
    19. Szirmai LA, Arnold C, Farsang C. Improving control of hypertension by an integrated approach - results of the "Manage it well!" programme. J Hypertens 2005; 23: 203-211. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.